InvestorsHub Logo
Followers 4
Posts 163
Boards Moderated 0
Alias Born 02/10/2014

Re: pennytiger post# 297153

Friday, 08/26/2022 10:21:31 AM

Friday, August 26, 2022 10:21:31 AM

Post# of 331118
The R&D category of the balance sheets could definitely be including things like the developmental changes of the RecoveryRX loop size, and power. The money spent is probably to attain sales from those medical professionals who have tested it, liked it, but wanted small changes to make it more applicable. So it may be very important to have spent the money in the R&D space, it could be the reason there is a 975,000 unit sale under contract.